Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial
Business Wire India Invivoscribe Inc., a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to…
